12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target

Objectives Gout is often not adequately treated, and we aimed to apply urate lowering treatment (ULT) combined with individual information to achieve target serum urate (sUA) in clinical practice, and to identify predictors of achievement of this sUA target.Methods Patients with a recent gout flare...

Full description

Bibliographic Details
Main Authors: Till Uhlig, Espen A Haavardsholm, Lars F Karoliussen
Format: Article
Language:English
Published: BMJ Publishing Group 2021-04-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/7/1/e001628.full
id doaj-03124d20a9cb4ec5bd839ecccf7dc00d
record_format Article
spelling doaj-03124d20a9cb4ec5bd839ecccf7dc00d2021-09-26T04:00:05ZengBMJ Publishing GroupRMD Open2056-59332021-04-017110.1136/rmdopen-2021-00162812-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this targetTill Uhlig0Espen A Haavardsholm1Lars F Karoliussen2professorprofessor1 Rheumatology, Diakonhjemmet Hospital, Oslo, NorwayObjectives Gout is often not adequately treated, and we aimed to apply urate lowering treatment (ULT) combined with individual information to achieve target serum urate (sUA) in clinical practice, and to identify predictors of achievement of this sUA target.Methods Patients with a recent gout flare and sUA >360 µmol/L (>6 mg/dL) were consecutively included in a single-centre study and managed with a treat-to-target approach combining nurse-led information about gout with ULT. All patients were assessed with tight controls at baseline, 1, 2, 3, 6, 9 and 12 months including clinical examination, information on demographics, lifestyle, self-efficacy and beliefs about medicines. The treatment target was sUA <360 µmol/L and multivariable logistic regression was used to identify predictors of target attainment with ORs and 95% CIs.Results Of 211 patients (mean age 56.4 years, disease duration 7.8 years, 95% males), 186 completed the 12-month study. Mean sUA levels decreased from baseline mean 500 to 311 µmol/L at 12 months with 85.5% achieving the treatment target. Alcohol consumption at least weekly versus less frequently (OR 0.14; 95% CI 0.04 to 0.55) as well as beliefs in overuse of medicines (OR per unit 0.77; 95 CI 0.62 to 0.94) decreased the chance of reaching the treatment target, while higher self-efficacy for arthritis symptoms (OR 1.49 per 10 units; 95% CI 1.09 to 2.05) increased the likelihood.Conclusions This study shows that target sUA can be achieved with ULT in most patients. Less self-reported alcohol consumption, low beliefs in overuse of medicines and higher self-efficacy are associated with treatment success.https://rmdopen.bmj.com/content/7/1/e001628.full
collection DOAJ
language English
format Article
sources DOAJ
author Till Uhlig
Espen A Haavardsholm
Lars F Karoliussen
spellingShingle Till Uhlig
Espen A Haavardsholm
Lars F Karoliussen
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
RMD Open
author_facet Till Uhlig
Espen A Haavardsholm
Lars F Karoliussen
author_sort Till Uhlig
title 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
title_short 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
title_full 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
title_fullStr 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
title_full_unstemmed 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
title_sort 12-month results from the real-life observational treat-to-target and tight-control therapy nor-gout study: achievements of the urate target levels and predictors of obtaining this target
publisher BMJ Publishing Group
series RMD Open
issn 2056-5933
publishDate 2021-04-01
description Objectives Gout is often not adequately treated, and we aimed to apply urate lowering treatment (ULT) combined with individual information to achieve target serum urate (sUA) in clinical practice, and to identify predictors of achievement of this sUA target.Methods Patients with a recent gout flare and sUA >360 µmol/L (>6 mg/dL) were consecutively included in a single-centre study and managed with a treat-to-target approach combining nurse-led information about gout with ULT. All patients were assessed with tight controls at baseline, 1, 2, 3, 6, 9 and 12 months including clinical examination, information on demographics, lifestyle, self-efficacy and beliefs about medicines. The treatment target was sUA <360 µmol/L and multivariable logistic regression was used to identify predictors of target attainment with ORs and 95% CIs.Results Of 211 patients (mean age 56.4 years, disease duration 7.8 years, 95% males), 186 completed the 12-month study. Mean sUA levels decreased from baseline mean 500 to 311 µmol/L at 12 months with 85.5% achieving the treatment target. Alcohol consumption at least weekly versus less frequently (OR 0.14; 95% CI 0.04 to 0.55) as well as beliefs in overuse of medicines (OR per unit 0.77; 95 CI 0.62 to 0.94) decreased the chance of reaching the treatment target, while higher self-efficacy for arthritis symptoms (OR 1.49 per 10 units; 95% CI 1.09 to 2.05) increased the likelihood.Conclusions This study shows that target sUA can be achieved with ULT in most patients. Less self-reported alcohol consumption, low beliefs in overuse of medicines and higher self-efficacy are associated with treatment success.
url https://rmdopen.bmj.com/content/7/1/e001628.full
work_keys_str_mv AT tilluhlig 12monthresultsfromthereallifeobservationaltreattotargetandtightcontroltherapynorgoutstudyachievementsoftheuratetargetlevelsandpredictorsofobtainingthistarget
AT espenahaavardsholm 12monthresultsfromthereallifeobservationaltreattotargetandtightcontroltherapynorgoutstudyachievementsoftheuratetargetlevelsandpredictorsofobtainingthistarget
AT larsfkaroliussen 12monthresultsfromthereallifeobservationaltreattotargetandtightcontroltherapynorgoutstudyachievementsoftheuratetargetlevelsandpredictorsofobtainingthistarget
_version_ 1716868515572482048